VEEV•Veeva Systems said it remains on track for its $6 billion 2030 target. Its estimated life sciences addressable market exceeds $30 billion, while its quality business has a revenue run rate above $600 million and more than 600 customers.
Veeva Systems said it remains on track for its $6 billion target in 2030, citing its November 5, 2026, investor presentation. The company estimated its life sciences addressable market at more than $30 billion and said the biopharma and medical technology industry is growing more than 6%.
Veeva’s quality business has a revenue run rate exceeding $600 million and serves more than 600 customers.
